Orthofix Medical today announced the limited market release and first implant of its Virtuos Lyograft autograft substitute.
Lewisville, Texas-based Orthofix designed Virtuos Lyograft as a shelf-stable and complete autograft substitute for spine and orthopedic procedures. It is prepared by MTF Biologics through a process that preserves all biologic components needed for bone healing within the graft.
“The Virtuos allograft is unique in the fact that it can be stored at room temperature and is ready to implant within two minutes of being hydrated,” said Dr. Tomas Ellis, a neurosurgeon at Baylor Scott and White Surgical Hospital in Fort Worth, Texas, who implanted the first patient. “This helps ensure we can always have an easy-to-use, moldable, complete bone graft on hand, and it streamlines the preparation and overall surgical procedure time.”
Virtuos Lyograft is an addition to the company’s line of biologics that includes the Trinity Elite, Trinity Evolution, FiberFuse Advanced and FiberFuse Strip allografts.
“The Virtuos Lyograft provided through our exclusive partnership with MTF Biologics is at the forefront of allograft technology,” said Orthofix President of Global Spine Kevin Kenny. “Processed through a proprietary preservation method, Virtuos provides the best of both worlds. It delivers a high-quality shelf-stable bone graft with the clinical performance and superior handling that clinicians desire, as well as streamlined logistics for storage and preparation for the hospital.”
